CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Artemisinin

青蒿素 杂质对照品Artemisinin Impurities

37 个杂质条目37 impurity entries

本页汇总 青蒿素 的 37 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 37 impurity reference standards of Artemisinin. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 青蒿素(Artemisinin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesRaman study of impurity influence on active center in artemisinin
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2019 · Hou HY et al.  ·  PMID 31154240  ·  DOI
  2. 杂质研究Impurity studiesDetermination of artemether and dihydroartemisinin in human plasma with a new hydrogen peroxide stabilization method
    Bioanalysis · 2013 · Huang L et al.  ·  PMID 23795928  ·  DOI
  3. 杂质研究Impurity studiesDihydroartemisinin-cyclodextrin complexation: solubility and stability
    Archives of pharmacal research · 2009 · Ansari MT et al.  ·  PMID 19183889  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activity
    European journal of medicinal chemistry · 2021 · Wei MX et al.  ·  PMID 33636536  ·  DOI
  • 合成方法SynthesisSynthesis of Mono- and Bisperoxide-Bridged Artemisinin Dimers to Elucidate the Contribution of Dimerization to Antimalarial Activity
    ACS infectious diseases · 2021 · Lichorowic CL et al.  ·  PMID 33792305  ·  DOI

青蒿素 —— 原料药与杂质对照品Artemisinin — drug substance & impurities

共 38 个条目(含原料药本体)38 items incl. the drug substance
Artemisinin structure
原料药 APIAPI
青蒿素Artemisinin
Artemisinin
CAS No.63968-64-9
Chemical FormulaC15H22O5
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin Impurity B (9-epi Artemisinin) structure
B
青蒿素杂质4Artemisinin Impurity B (9-epi Artemisinin)
Artemisinin Impurity B (9-epi Artemisinin)
CAS No.113472-97-2
Chemical FormulaC15H22O5
Purity>95%询价On request
10mg25mg50mg100mg
Diketo aldehyde impurity of dihydroartemisinin structure
OF
Diketo aldehyde impurity of dihydroartemisinin
CAS No.—
Chemical FormulaC14H22O3
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinic Alcohol structure
—
Dihydro Artemisinic Alcohol
CAS No.106549-22-8
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
(11S)-Dihydroartemisinic Acid structure
—
(11S)-Dihydroartemisinic Acid
CAS No.110715-68-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinic Aldehyde structure
—
Dihydro Artemisinic Aldehyde
CAS No.125184-93-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinic Alcohol structure
—
Artemisinic Alcohol
CAS No.125184-95-4
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinic Aldehyde structure
—
Artemisinic Aldehyde
CAS No.125276-60-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
3-Hydroxy-Desoxydihydro Artemisinin structure
—
3-Hydroxy-Desoxydihydro Artemisinin
CAS No.126641-61-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinin (Mixture of alpha and beta Isomers) structure
—
Dihydro Artemisinin (Mixture of alpha and beta Isomers)
CAS No.131175-87-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinin-d3 structure
—
Dihydro Artemisinin-d3
CAS No.176774-98-4
Chemical Formula—
Purity>95%询价On request
Dihydro Artemisinin Tetrafurano Acetate structure
—
Dihydro Artemisinin Tetrafurano Acetate
CAS No.198817-95-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinin D-Glucuronide structure
—
Dihydro Artemisinin D-Glucuronide
CAS No.198976-06-6
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Arteannuin H structure
—
Arteannuin H
CAS No.207446-83-1
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
(11S)-Dihydroartemisinic Aldehyde structure
—
(11S)-Dihydroartemisinic Aldehyde
CAS No.28386-58-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Gamma-Muurolene structure
—
Gamma-Muurolene
CAS No.30021-74-0
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinin structure
—
Dihydro Artemisinin
CAS No.71939-50-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Deoxy-Dihydroartemisinin structure
—
Deoxy-Dihydroartemisinin
CAS No.72807-92-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Deoxy Artemisinin structure
—
青蒿素杂质8Deoxy Artemisinin
Deoxy Artemisinin
CAS No.72826-63-2
Chemical FormulaC15H22O4
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinic Acid structure
—
青蒿素杂质3Artemisinic Acid
Artemisinic Acid
CAS No.80286-58-4
Chemical FormulaC15H22O2
Purity>95%询价On request
10mg25mg50mg100mg
9,10-Anhydrodihydro Artemisinin structure
—
青蒿素杂质19,10-Anhydrodihydro Artemisinin
9,10-Anhydrodihydro Artemisinin
CAS No.82596-30-3
Chemical FormulaC15H22O4
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinic Acid structure
—
青蒿素杂质2Dihydro Artemisinic Acid
Dihydro Artemisinic Acid
CAS No.85031-59-0
Chemical FormulaC15H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Amorphadiene structure
—
青蒿素杂质9 (紫穗槐二烯)Amorphadiene
Amorphadiene
CAS No.92692-39-2
Chemical FormulaC15H24
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinic Acid Carbonate Impurity structure
—
Artemisinic Acid Carbonate Impurity
CAS No.—
Chemical FormulaC18H28O4
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinin-d4 structure
—
Dihydro Artemisinin-d4
CAS No.—
Chemical FormulaC15H20O5D4
Purity>95%询价On request
(11S)-Dihydroartemisinic Alcohol structure
—
(11S)-Dihydroartemisinic Alcohol
CAS No.—
Chemical FormulaC15H26O
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinin-13C-d4 structure
—
Dihydro Artemisinin-13C-d4
CAS No.—
Chemical Formula13CC14H20O5D4
Purity>95%询价On request
Artemisinin impurity 1 structure
1
青蒿素杂质1Artemisinin impurity 1
Artemisinin impurity 1
CAS No.—
Chemical FormulaC14H22O3
Purity>95%询价On request
10mg25mg50mg100mg
Dihydro Artemisinin Impurity 1 structure
1
Dihydro Artemisinin Impurity 1
CAS No.—
Chemical FormulaC15H24O5
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin impurity 2 structure
2
青蒿素杂质2Artemisinin impurity 2
Artemisinin impurity 2
CAS No.—
Chemical FormulaC16H26O5
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin impurity 3 structure
3
青蒿素杂质3Artemisinin impurity 3
Artemisinin impurity 3
CAS No.—
Chemical FormulaC16H26O5
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin impurity 4 structure
4
青蒿素杂质4Artemisinin impurity 4
Artemisinin impurity 4
CAS No.—
Chemical FormulaC14H22O4
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin impurity 5 structure
5
青蒿素杂质5Artemisinin impurity 5
Artemisinin impurity 5
CAS No.958447-27-3
Chemical FormulaC15H20O3
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin Impurity 6 structure
6
青蒿素杂质6Artemisinin Impurity 6
Artemisinin Impurity 6
CAS No.—
Chemical FormulaC14H19NO
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin Impurity 7 structure
7
青蒿素杂质7Artemisinin Impurity 7
Artemisinin Impurity 7
CAS No.150358-71-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin Impurity 8 structure
8
蒿甲醚杂质15Artemisinin Impurity 8
Artemisinin Impurity 8
CAS No.188591-96-0
Chemical FormulaC30H46O9
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin Impurity 9 structure
9
青蒿素杂质9Artemisinin Impurity 9
Artemisinin Impurity 9
CAS No.218603-11-3
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Artemisinin Impurity 10 structure
10
青蒿素杂质7Artemisinin Impurity 10
Artemisinin Impurity 10
CAS No.1453465-55-8
Chemical FormulaC16H26O5
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

青蒿素 —— 研究文献与合成路线Artemisinin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 青蒿素 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Artemisinin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: A possible link
    Geroldinger G, Tonner M, Quirgst J, et al. · Biochemical pharmacology · 2020 · 被引 18cited 18
  2. Discovery of D-Ring-Contracted Artemisinin as a Potent Hydrophobic Tag for Targeted Protein Degradation
    Qing L, Yu Q, Wang C, et al. · Journal of medicinal chemistry · 2025 · 被引 11cited 11
  3. Degradation of Artemisinin-Based Combination Therapies Under Tropical Conditions
    Hall Z, Allan EL, van Schalkwyk DA, et al. · The American journal of tropical medicine and hygiene · 2016 · 被引 14cited 14
  4. Raman study of impurity influence on active center in artemisinin
    Hou HY, Yang X, Mao ZL, et al. · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2019 · 被引 3cited 3
  5. Identification of CD40 as the target of artemisinin via targeted degradomics for ulcerative colitis
    Zhang Z, Song H, Li Y, et al. · Bioorganic chemistry · 2026
  6. Artemisinin-derived radicals trigger TGFβ oxidation and degradation for alopecia therapy
    Wang R, Wang C, Liu C, et al. · Biomaterials · 2026

合成与制备工艺专利Synthesis & process patents

  1. Process for manufacturing artemisinin
    VILLANOVA LUIGI, CISALE FELICIA, VILLANOVA AZZURA, VILLANOVA LUCIANO · 公开号 AU2008303781AU2008303781 · 2009
  2. A NEW SERIES OF ARTEMISININ DERIVATIVES AND PROCESS FOR PREPARATION THEREOF
    BAISHYA GAKUL, BARUA NABIN CHANDRA, GOSWAMI ABHISHEK, SAIKIA PARTHA PRATIM, et al. · 公开号 WO2011089507WO2011089507 · 2011
  3. PROCESS FOR MANUFACTURING ARTEMISININ
    VILLANOVA LUIGI, CISALE FELICIA, VILLANOVA AZZURRA, VILLANOVA LUCIANO · 公开号 US2010331553US2010331553 · 2010
  4. PROCESS FOR MANUFACTURING ARTEMISININ
    VILLANOVA LUIGI · 公开号 EP2201016EP2201016 · 2010
  5. PROCESS FOR MANUFACTURING ARTEMISININ
    — · 公开号 WO2009040119WO2009040119 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

青蒿素 杂质谱研究要点Artemisinin — impurity profiling notes

下面这些是拿到 青蒿素 的 38 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 38 impurity entries for Artemisinin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances